These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 38041547)

  • 1. Dysbiosis of lower respiratory tract microbiome are associated with proinflammatory states in non-small cell lung cancer patients.
    Li Y; Rao G; Zhu G; Cheng C; Yuan L; Li C; Gao J; Tang J; Wang Z; Li W
    Thorac Cancer; 2024 Jan; 15(2):111-121. PubMed ID: 38041547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysbiosis of lower respiratory tract microbiome are associated with inflammation and microbial function variety.
    Li KJ; Chen ZL; Huang Y; Zhang R; Luan XQ; Lei TT; Chen L
    Respir Res; 2019 Dec; 20(1):272. PubMed ID: 31796027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of the Human Lung and Gut Microbiomes in Non-Small Cell Lung Carcinomas and Distant Metastasis.
    Lu H; Gao NL; Tong F; Wang J; Li H; Zhang R; Ma H; Yang N; Zhang Y; Wang Y; Liang Z; Zeng H; Chen WH; Dong X
    Microbiol Spectr; 2021 Dec; 9(3):e0080221. PubMed ID: 34787462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between the lung microbiome and lung cancer.
    Mao Q; Jiang F; Yin R; Wang J; Xia W; Dong G; Ma W; Yang Y; Xu L; Hu J
    Cancer Lett; 2018 Feb; 415():40-48. PubMed ID: 29197615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-A review.
    Nagasaka M; Sexton R; Alhasan R; Rahman S; Azmi AS; Sukari A
    Crit Rev Oncol Hematol; 2020 Jan; 145():102841. PubMed ID: 31884204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung microbiome alterations in NSCLC patients.
    Zheng L; Sun R; Zhu Y; Li Z; She X; Jian X; Yu F; Deng X; Sai B; Wang L; Zhou W; Wu M; Li G; Tang J; Jia W; Xiang J
    Sci Rep; 2021 Jun; 11(1):11736. PubMed ID: 34083661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated microbiome, metabolome, and proteome analysis identifies a novel interplay among commensal bacteria, metabolites and candidate targets in non-small cell lung cancer.
    Qian X; Zhang HY; Li QL; Ma GJ; Chen Z; Ji XM; Li CY; Zhang AQ
    Clin Transl Med; 2022 Jun; 12(6):e947. PubMed ID: 35735103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiome: A Supportive or a Leading Actor in Lung Cancer?
    Martins D; Mendes F; Schmitt F
    Pathobiology; 2021; 88(2):198-207. PubMed ID: 33352574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysbiosis of skin microbiome and gut microbiome in melanoma progression.
    Mekadim C; Skalnikova HK; Cizkova J; Cizkova V; Palanova A; Horak V; Mrazek J
    BMC Microbiol; 2022 Feb; 22(1):63. PubMed ID: 35216552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of lower respiratory tract microbiome and short-chain fatty acids in different segments in lung cancer: a multiomics analysis.
    Zhang Y; Chen X; Wang Y; Li L; Ju Q; Zhang Y; Xi H; Wang F; Qiu D; Liu X; Chang N; Zhang W; Zhang C; Wang K; Li L; Zhang J
    Front Cell Infect Microbiol; 2023; 13():1261284. PubMed ID: 37915846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
    Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
    mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non-small-cell lung cancer patients.
    Zhang C; Wang J; Sun Z; Cao Y; Mu Z; Ji X
    Cancer Sci; 2021 Aug; 112(8):3005-3017. PubMed ID: 34028936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancer.
    Zhou X; You L; Xin Z; Su H; Zhou J; Ma Y
    J Transl Med; 2023 Nov; 21(1):800. PubMed ID: 37950236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symbiotic microbial communities in various locations of the lung cancer respiratory tract along with potential host immunological processes affected.
    Cheng J; Zhou L; Wang H
    Front Cell Infect Microbiol; 2024; 14():1296295. PubMed ID: 38371298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysbiosis of the gut and lung microbiome has a role in asthma.
    Hufnagl K; Pali-Schöll I; Roth-Walter F; Jensen-Jarolim E
    Semin Immunopathol; 2020 Feb; 42(1):75-93. PubMed ID: 32072252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer.
    Rao Malla R; Marni R; Kumari S; Chakraborty A; Lalitha P
    Clin Breast Cancer; 2022 Apr; 22(3):200-211. PubMed ID: 34625387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis.
    Frey DL; Boutin S; Dittrich SA; Graeber SY; Stahl M; Wege S; Herth FJF; Sommerburg O; Schultz C; Mall MA; Dalpke AH
    J Cyst Fibros; 2021 Sep; 20(5):754-760. PubMed ID: 33431308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the microbiome composition in lower respiratory tract at different sites in early lung cancer patients.
    Su K; Gao Y; He J
    Transl Lung Cancer Res; 2023 Jun; 12(6):1264-1275. PubMed ID: 37425420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host-Microbiome Interaction in Lung Cancer.
    Dong Q; Chen ES; Zhao C; Jin C
    Front Immunol; 2021; 12():679829. PubMed ID: 34108973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation Analysis between Gut Microbiota Alterations and the Cytokine Response in Patients with Coronavirus Disease during Hospitalization.
    Mizutani T; Ishizaka A; Koga M; Ikeuchi K; Saito M; Adachi E; Yamayoshi S; Iwatsuki-Horimoto K; Yasuhara A; Kiyono H; Matano T; Suzuki Y; Tsutsumi T; Kawaoka Y; Yotsuyanagi H
    Microbiol Spectr; 2022 Apr; 10(2):e0168921. PubMed ID: 35254122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.